Gateshead, England (ots/PRNewswire) - On the 1st September 2006,
Medify Solutions Limited will roll out its 'remote access to patient
notes' product, MedifyRemote, to its National Health Service (NHS)
customers. The first NHS site, as published previously , will be in
Doncaster in the north of England.
This site is leading the way for the rest of the UK in terms of
development and user testing of the powerful Medify Remote live
product, which will bring many benefits for patients and users in
terms of greater efficiency and more accurate transfer of
Operating through its N3 approved secure connection to the NHS
patient database; Medify will begin the roll out to its live NHS
customers. This will be coordinated through corporate partners who
are providing the patient record software and airtime connection to
The sales potential for Medify Remote is significant. For ease of
understanding, the product will be offered to the customer at a
monthly charge in the region of US$85 per month. In the UK there are
over 500 000 healthcare professionals, the primary target user. Thus
the market for Medify in the UK alone is US$510m per annum (85 x 500
000 x 12).
Therefore for every 1% market penetration, the revenue for Medify
is $ 5.1m per annum.
Medify has the approved connection to NHS' N3, the secure national
IT network and has contracts to provide the service to NHS
Healthcare professionals, which will now roll out over the next 12
months. As the only provider to offer the service Medify is set to
achieve significant revenues starting on the 1st of September 2006.
Of further importance is that UK Healthcare professionals
represent approximately 10% of the overall European market and
approximately 1% of a total global market of 59 million
professionals (potential users).
Contact : firstname.lastname@example.org
Company website : www.medifysolutions.com
This news release contains forward-looking statements that are
subject to certain risks and uncertainties that may cause actual
results to differ materially from those projected on the basis of
such forward-looking statements. The words "estimate," "project,"
"intends," "expects," " believes," and similar expressions are
intended to identify forward-looking statements. Such
forward-looking statements are made based on management's beliefs,
as well as assumptions made by, and information currently available
to, management pursuant to the "safe-harbour" provisions of the
Private Securities Litigation Reform Act of 1995. For a more complete
description of these and other risk factors that may affect the
future performance of Medify Solutions Limited, see "Risk Factors"
in the Company's Annual Report on Form 10-KSB and its other filings
with the Securities and Exchange Commission. Readers are cautioned
not to place undue reliance on these forward-looking statements,
which speak only as of the date made and the Company undertakes no
obligation to disclose any revision to these forward-looking
statements to reflect events or circumstances after the date made or
to reflect the occurrence of unanticipated events.
ots Originaltext: Medify Solutions Ltd.
Im Internet recherchierbar: http://www.presseportal.ch
For further information: Jonathan Bryant, Group Chairman, Medify
Solutions, Tel: +44-(0)845-034-4090, Fax: +44-(0)1785-214474,